25-Mar-2015 - Sourcing human beta cells may soon no longer be a challenge for AstraZeneca diabetes researchers thanks to a new partnership with stem cell scientists at Harvard University.
News in brief
25-Mar-2015 - Novasep and Lonza will both make the API for Celladon's heart attack therapy, Mydicar.
Register now for our free online event
25-Mar-2015 - Want the latest market information, and scientific insights in the pharmaceutical excipients market? Then join us at our free online event, Excipients Innovations 2015.
24-Mar-2015 - Demand for pensioner friendly pills will be an important growth driver for the drug excipients sector according to new analysis.
20-Mar-2015 - Eli Lilly and China biotech Innovent Biologics will collaborate to develop at least three cancer treatments over the next decade.
17-Mar-2015 - NSF International has published a new standard and developed an auditing program that can help pharma companies verify regulatory compliance and strengthen safety and quality across their excipient supply chain.
News in brief
16-Mar-2015 - Porton Fine Chemicals will buy fellow China-based firm Jiangxi Dongbang Pharmaceutical adding intermediates for antivirals and cholesterol busters to its portfolio.
12-Mar-2015 - The FDA has tested hundreds of creatively named bogus supplements and found they contain hidden APIs. Take in-Pharmatechnologist.com's quiz and tell us which name is your favourite.
Ingredients: Featured news
John Giannone - incoming IPEC-Americas chairman
Irwin Silverstein, COO and VP of the International Pharmaceutical Excipients...
in-Pharmatechnologist.com presents a roundup of news in the fine chemicals sector, beginning with Johnson Matthey which has started a review of its active pharmaceutical ingredient (API) business after competition in the UK impacted its third quarter margins.